199TiP A first-in-human phase I study of IPH5301, an anti-CD73 monoclonal antibody, alone or in combination with chemotherapy and trastuzumab, in patients with advanced solid tumors (CHANCES)

A. Gonçalves, C. Vicier, M. Guerin, J. Pignon, B. Chanez, M. Provansal Gross, N. Penel, N. Kotecki, D.B. Marie, A. Boyer Chammard, C.L. Paturel, P. André,J. Pakradouni,J.M. Boher, F. Awada

Immuno-Oncology and Technology（2022）

引用 0|浏览6